Founded in Paris in 1920, Gide is a leading international law firm with 12 offices spread throughout the world.
Gide is physically present in six regions of the world, with 11 offices, enabling it to act on cases globally.
Practice areaIndustry sector |
Specialty |
Mélanie Simon is an associate in French and US law. She mainly advises on capital markets and cross-border M&A transactions.
Member of the Paris and New York bars since 2019, she has been involved in the IPOs of Valneva, Nanobiotix, Inventiva and Innate Pharma on Nasdaq, the private placements of GenSight Biologics, Nanobiotix and Eos imaging and the sale of a block of Alstom shares by Bouygues.
Mélanie holds Masters degrees in tax law and banking and finance law from the University of Paris II Panthéon Assas and is also a graduate of New York University Law School.
